The IDH1 protein helps turn the food we eat into chemical energy that powers our cells. However, an alteration in just one of the protein’s amino acids has also been linked to brain and blood cancer. Recent research describes a newly designed compound that binds to IDH1, and measurements lay the foundation for further investigations in anticancer drug development and basic research.